Diabetic Gastroparesis Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies – Allergan, Evoke Pharma, Theravance Biopharma, Censa Pharma, CinDome, and Others

 Breaking News
  • No posts were found

Diabetic Gastroparesis Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies – Allergan, Evoke Pharma, Theravance Biopharma, Censa Pharma, CinDome, and Others

August 01
17:02 2022
Diabetic Gastroparesis Market to Register Incremental Growth by 2032, Asserts DelveInsight | Key Companies - Allergan, Evoke Pharma, Theravance Biopharma, Censa Pharma, CinDome, and Others
Delveinsight Business Research LLP
As per DelveInsight, the Diabetic Gastroparesis Market dynamics are expected to transform in the coming years owing to the launch of emerging therapies, ongoing Research and Development (R&D) activities, and the active participation of the global pharma and biotech giants in the therapeutic segment. Several key companies are active in the therapeutic domain, and the therapies under development are focused on novel approaches to treat the disease.

DelveInsight’s “Diabetic Gastroparesis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Diabetic Gastroparesis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Diabetic Gastroparesis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Diabetic Gastroparesis Market

Diabetic Gastroparesis: An Overview

The term Diabetic Gastroparesis (DGp) has been used to describe a serious complication of diabetes resulting in delayed gastric emptying with associated upper gastrointestinal (GI) symptoms in the absence of any mechanical obstruction.

Patients with DGp often present with gastric comorbidities, including gastroesophageal reflux disease, intestinal dysmotility, and fungal and bacterial infections of the GI tract, as well as with macro-and microvascular complications of diabetes. Therefore, effective management of patients with DGP often requires an interdisciplinary approach with the involvement of a team of specialists

Diabetic Gastroparesis Market Key Facts

  • It has been observed that the prevalence of both T1DM and T2DM-associated Diabetic Gastroparesis was highest in the United States.

  • Among the European 5 countries, Germany had the highest prevalent population of Diabetic Gastroparesis, followed by the United Kingdom and Italy.

  • Among Diabetic Gastroparesis patients, females account for a higher number of Diabetic Gastroparesis cases than males. 

  • About 40% of patients with Type 1 Diabetes have gastroparesis as per studies carried out in tertiary care centres while approximately 30% of Type 2 DM cases suffer from DGp.

Diabetic Gastroparesis Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Diabetic Gastroparesis market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Diabetic Gastroparesis market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Diabetic Gastroparesis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Diabetic Gastroparesis Drugs Uptake and Pipeline Development Activities

The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Gastroparesis market or expected to be launched during the study period. The analysis covers Diabetic Gastroparesis market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Diabetic Gastroparesis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size

Diabetic Gastroparesis Therapeutics Analysis

The available treatment options in the Diabetic Gastroparesis Landscape aim to improve the efficiency of the gastric pump and relieve symptoms of nausea, bloating, vomiting, and pain. Some of the companies are working on novel therapeutic approaches that can entirely change the treatment landscape of Diabetic Gastroparesis in the upcoming years. 

Some of the key pharma players in the Diabetic Gastroparesis market include:

  • Allergan

  • Evoke Pharma 

  • Theravance Biopharma

  • Censa Pharmaceuticals

  • CinDome Pharma

And many others.

Diabetic Gastroparesis (DGp) Therapies covered in the report include:

  • Relamorelin

  • Gimoti

  • Velusetrag

  • CNSA-001

  • CIN-102

And many others

Get More Detailed Insights Into the Emerging Therapies & Key Companies  –  https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Diabetic Gastroparesis Competitive Intelligence Analysis

4. Diabetic Gastroparesis Market Overview at a Glance

5. Diabetic Gastroparesis Disease Background and Overview

6. Diabetic Gastroparesis Patient Journey

7. Diabetic Gastroparesis Epidemiology and Patient Population

8. Diabetic Gastroparesis Treatment Algorithm, Current Treatment, and Medical Practices

9. Diabetic Gastroparesis Unmet Needs

10. Key Endpoints of Diabetic Gastroparesis Treatment

11. Diabetic Gastroparesis Marketed Products

12. Diabetic Gastroparesis Emerging Therapies

13. Diabetic Gastroparesis Seven Major Market Analysis

14. Attribute Analysis

15. Diabetic Gastroparesis Market Outlook (7 major markets)

16. Diabetic Gastroparesis Access and Reimbursement Overview

17. KOL Views on the Diabetic Gastroparesis Market.

18. Diabetic Gastroparesis Market Drivers

19. Diabetic Gastroparesis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/diabetic-gastroparesis-market-size

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Scleritis Market
“Scleritis Market” research report provides a detailed overview of the historical and forecasted epidemiology and the Scleritis Market size, share, and trends in the 7MM. Additionally, it also covers the latest innovations, breakthroughs, emerging therapies, and key companies operating in the therapeutics Market. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/